<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33896281</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7-8</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010-2018.</ArticleTitle><Pagination><StartPage>535</StartPage><EndPage>544</EndPage><MedlinePgn>535-544</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1910308</ELocationID><Abstract><AbstractText><i>Background</i>: Previous research has suggested that vigorous physical activity (VPA) during adolescence and early adulthood is associated with ALS. The National ALS Registry (Registry) collects physical activity data from persons with ALS. <i>Objective:</i> To examine the association between vigorous VPA and early onset ALS, defined as a diagnosis before age 60, among patients enrolled in the Registry. VPA was defined as engaging in dynamic exercise for at least 10&#x2009;minutes in a session that caused heavy sweating or large increases in breathing or heart rate. <i>Methods:</i> A cross-sectional study was conducted of 5463 ALS patients with VPA history and 956 ALS patients who never engaged in VPA. Patient characteristics were collected via online surveys in the following areas: demographic, lifetime VPA history, and initial onset of symptoms. General linear modeling was used to estimate mean age of diagnosis and to compute 95% confidence intervals. <i>Results:</i> Patients who reported engaging in VPA at least moderately (three times a week) during early adulthood were more likely to have an ALS diagnosis earlier compared to patients who did not (<i>p</i>&#x2009;&lt;&#x2009;0.0001). After controlling for year of birth, statistically significant associations between those reporting VPA at age 15-24 and 25-34 and diagnosis of ALS earlier (<i>p</i>&#x2009;=&#x2009;0.0009, <i>p</i>&#x2009;=&#x2009;0.0144 respectively). <i>Conclusion:</i> Patients with ALS who had a history of VPA before age 35, were significantly more likely to be diagnosed with ALS before age 60 compared to patients with ALS who never engaged vigorously. More research is needed in the relationship between VPA and early onset ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raymond</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Ted</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Factor-Litvak</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Mailman School of Public Health, Columbia University, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Bryn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007899" MajorTopicYN="N">Leisure Activities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">exercise</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">physical activity</Keyword></KeywordList><CoiStatement>Declaration of interest. The CDC/ATSDR authors have no declarations of interest. Dr. Factor-Litvak has no declarations of interest linked to the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>26</Day><Hour>5</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33896281</ArticleId><ArticleId IdType="mid">NIHMS1745619</ArticleId><ArticleId IdType="pmc">PMC8559906</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1910308</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al., Amyotrophic lateral sclerosis. Lancet, 2011. 377(9769): p. 942&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., et al., Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015. MMWR Morb Mortal Wkly Rep, 2018. 67(46): p. 1285&#x2013;1289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Deux CJA, Deux cas d&#x2019;atrophie musculaire progressive avec lesions de la susstance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch Physiol neurol Pathol, 1869. 2.</Citation></Reference><Reference><Citation>Wagner L., et al., State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener, 2015. 17(1&#x2013;2): p. 128&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4732418</ArticleId><ArticleId IdType="pubmed">26399278</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, McDermott CJ, and Shaw PJ, Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler, 2009. 10(4): p. 191&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Longstreth WT, et al., Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses, 1991. 34(2): p. 144&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2041488</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanacore N., et al., Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotroph Lateral Scler, 2010. 11(5): p. 430&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20698805</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland D., et al., Physical activity, trauma, and ALS: a case-control study. Acta Neurol Scand, 1996. 94(1): p. 45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">8874593</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N., et al., Premorbid weight, body mass, and varsity athletics in ALS. Neurology, 2002. 59(5): p. 773&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221178</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E., et al., Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler, 2010. 11(3): p. 289&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3513269</ArticleId><ArticleId IdType="pubmed">20433412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman EJ, et al., Neurodegenerative causes of death among retired National Football League players. Neurology, 2012. 79(19): p. 1970&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., et al., Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 2005. 128(Pt 3): p. 472&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, et al., Prospective study of military service and mortality from ALS. Neurology, 2005. 64(1): p. 32&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15642900</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., et al., ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler, 2009. 10(4): p. 205&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, et al., Family history of neurodegenerative and vascular diseases in ALS: a population-based study. Neurology, 2011. 77(14): p. 1363&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21940614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacorte E., et al., Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neurosci Biobehav Rev, 2016. 66: p. 61&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">27108217</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, et al., Physical activity and the association with sporadic ALS. Neurology, 2005. 64(2): p. 241&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15668420</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, et al., Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 2013. 84(9): p. 976&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">23418211</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., et al., Extensive genetics of ALS: a population-based study in Italy. Neurology, 2012. 79(19): p. 1983&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484987</ArticleId><ArticleId IdType="pubmed">23100398</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., et al., Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol, 2016. 15(11): p. 1182&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Service UPH, ALS registry act. 110th congress. Public Law., U.P.H. Service, Editor. 2008, US Public Health Service: Washington DC. p. 110&#x2013;373.</Citation></Reference><Reference><Citation>Brooks, B.R., El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci, 1994. 124 Suppl: p. 96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Antao VC and Horton DK, The National Amyotrophic Lateral Sclerosis (ALS) Registry. J Environ Health, 2012. 75(1): p. 28&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549968</ArticleId><ArticleId IdType="pubmed">22866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen KD, et al., The National Registry of Veterans with amyotrophic lateral sclerosis. Neuroepidemiology, 2008. 30(3): p. 180&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">18421218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al., The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci, 1999. 169(1&#x2013;2): p. 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton DK, Mehta P, and Antao VC, Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model. JAMA, 2014. 312(11): p. 1097&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550214</ArticleId><ArticleId IdType="pubmed">25057819</ArticleId></ArticleIdList></Reference><Reference><Citation>Services, U.D.o.H.a.H., US department of health and human services regions., U.D.o.H.a.H. Services, Editor. 2017: Washington DC.</Citation></Reference><Reference><Citation>Bryan L., et al., Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data. PLoS One, 2016. 11(4): p. e0153683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849726</ArticleId><ArticleId IdType="pubmed">27124833</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenland S, Pearl J, and Robins JM, Causal diagrams for epidemiologic research. Epidemiology, 1999. 10(1): p. 37&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">9888278</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong T, Bull F., Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health 2006(14): p. 5.</Citation></Reference><Reference><Citation>Rudolf K., et al., Show cards of the Global Physical Activity Questionnaire (GPAQ) - do they impact validity? A crossover study. BMC Public Health, 2020. 20(1): p. 223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017628</ArticleId><ArticleId IdType="pubmed">32050940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasan-Taber L., et al., Reproducibility of a self-administered lifetime physical activity questionnaire among female college alumnae. Am J Epidemiol, 2002. 155(3): p. 282&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11821254</ArticleId></ArticleIdList></Reference><Reference><Citation>Khishchenko N., et al., Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler, 2010. 11(1&#x2013;2): p. 125&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">19153849</ArticleId></ArticleIdList></Reference><Reference><Citation>Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser, 1995. 854: p. 1&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper KH, The History of Aerobics (50 Years and Still Counting). Res Q Exerc Sport, 2018. 89(2): p. 129&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">29723136</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute, S., SAS 9.4. Cary, NC.</Citation></Reference><Reference><Citation>Eisen A., Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve, 1995. 18(7): p. 741&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783764</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburton DER and Bredin SSD, Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol, 2017. 32(5): p. 541&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">28708630</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat S., et al., Exercise and Type 2 Diabetes. Adv Exp Med Biol, 2020. 1228: p. 91&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">32342452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuzeki E, Engeroff T, and Banzer W., Health Benefits of Light-Intensity Physical Activity: A Systematic Review of Accelerometer Data of the National Health and Nutrition Examination Survey (NHANES). Sports Med, 2017. 47(9): p. 1769&#x2013;1793.</Citation><ArticleIdList><ArticleId IdType="pubmed">28393328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E., et al., Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol, 2014. 75(5): p. 708&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">24706338</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna J., et al., Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol (Paris), 2017. 173(5): p. 244&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">28477849</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidou B., et al., Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment. Amyotroph Lateral Scler Frontotemporal Degener, 2017. 18(7&#x2013;8): p. 519&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">28762856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg J., et al., Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener, 2018. 19(1&#x2013;2): p. 7&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">28799809</ArticleId></ArticleIdList></Reference><Reference><Citation>August KJ and Sorkin DH, Racial/ethnic disparities in exercise and dietary behaviors of middle-aged and older adults. J Gen Intern Med, 2011. 26(3): p. 245&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3043172</ArticleId><ArticleId IdType="pubmed">20865342</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades JA, Exercise in Adults, Age 18 and Older, in the United States, 2002: Estimates for the Noninstitutionalized Population, Quality A.f.H.R.a., Editor. 2005: Medical Expenditure Panel Survey.</Citation></Reference><Reference><Citation>Simioni C., et al., Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget, 2018. 9(24): p. 17181&#x2013;17198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5908316</ArticleId><ArticleId IdType="pubmed">29682215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura T and Muraoka I., Exercise-Induced Oxidative Stress and the Effects of Antioxidant Intake from a Physiological Viewpoint. Antioxidants (Basel), 2018. 7(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6162669</ArticleId><ArticleId IdType="pubmed">30189660</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., et al., Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep, 2017. 7(1): p. 9094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon MS, et al., Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve, 2019. 59(1): p. 10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kats D., et al., Leisure-time physical activity volume, intensity, and duration from mid- to late-life in U.S. subpopulations by race and sex. The Atherosclerosis Risk In Communities (ARIC) Study. Aging (Albany NY), 2020. 12(5): p. 4592&#x2013;4602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093185</ArticleId><ArticleId IdType="pubmed">32170049</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray TC, Rodgers WM &amp; Fraser SN, Exploring the relationship between socioeconomic status, control beliefs and exercise behavior: a multiple mediator model. J Behav Med, 2012. 35: p. 63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">21442246</ArticleId></ArticleIdList></Reference><Reference><Citation>Bureau UC, Total population 2014 American community survey 1-year, U.D.o. Commerce, Editor. 2014, US Census Bureau Washington DC.</Citation></Reference><Reference><Citation>Watanabe H., et al., Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener, 2015. 16(3&#x2013;4): p. 230&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25548957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye WE, et al., Evaluating the completeness of the national ALS registry, United States. Amyotroph Lateral Scler Frontotemporal Degener, 2018. 19(1&#x2013;2): p. 112&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815913</ArticleId><ArticleId IdType="pubmed">29020837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>